Cryoablation
12
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
17%
2 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (12)
Correlation Between Diagnostic Nerve Block Response and Cryoneurolysis Outcome in Chronic Musculoskeletal Disorders
One-stop Diagnosis and Treatment for Suspected Lung Cancer: Combined RBS, nClE, OBCT and Ablation
The Best Workflow for Paroxysmal Supraventricular Tachycardia Ablation With Zero-fluoroscopy
Randomized Trial of HIFU vs. Cryo for Prostate Cancer
Infant and Child European Cryoablation Project ICECaP
Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases
Cryoablation for Advanced Bone and Soft Tissue Tumors
Remimazolam vs Desflurane for General Anesthesia for Ablation of Arrhythmia
Wide Area Circumferential Ablation With Contact Force Versus Cryoballoon Ablation
A Pilot Investigation Detecting Cryoablation Scar by 3D Late Gadolinium Enhancement
Comparison of Microwave Ablation With Cryoablation for Breast Tumor
Standardization of Multi-modal Tumor Ablation Therapy System